Warning: fopen(http://209.61.252.196/pn1.txt) [function.fopen]: failed to open stream: HTTP request failed! HTTP/1.1 404 Not Found in /home/zengshi0/domains/travelonlinedoctor.net/public_html/post.php on line 295
Development of an Antiviral Screening Protocol: One-Stone-Two-Birds. - Travel Doctor Online

 

Development of an Antiviral Screening Protocol: One-Stone-Two-Birds.

Authors:
Address: Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612.
Journal:


Publication:
Free Text: Development of an Antiviral Screening Protocol: One-Stone-Two-Birds.

abstract

As prophylactic therapies and vaccines against viral infections continue to improve, drug resistant strains are continuing to arise; therefore it is imperative to develop new therapeutics against these diseases. For highly pathogenic viruses, such as Ebola and H5N1 influenza virus, the need for Antivirals is even more urgent due to limited therapeutics against these viruses. Furthermore, the high pathogenicity of such viruses often makes it difficult to work with such agents. In this report, we describe a Protocol called "One-Stone-Two-Birds" which provides a safe and efficient Screening system to identify anti-flu (entry) and anti-HIV (replication) activities. Using plant extracts as an example, we demonstrate the utility of this protocol in antiviral screening.



Related Articles
A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
Antiviral Res. 2007
A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
Ehrhardt C, Hrincius ER, Korte V, Mazur I, Droebner K, Poetter A, Dreschers S, Schmolke M, Planz O, Ludwig S. Antiviral Res. 2007 Oct; 76(1):38-47. Epub 2007 Jun 4.
Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Antiviral Res. 2011
Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses.
Haasbach E, Pauli EK, Spranger R, Mitzner D, Schubert U, Kircheis R, Planz O. Antiviral Res. 2011 Sep; 91(3):304-13. Epub 2011 Jul 13.
Review Silver nanoparticles as potential antiviral agents.
Molecules. 2011
Review Silver nanoparticles as potential antiviral agents.
Galdiero S, Falanga A, Vitiello M, Cantisani M, Marra V, Galdiero M. Molecules. 2011 Oct 24; 16(10):8894-918. Epub 2011 Oct 24.
Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
PLoS One. 2009
Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
Triana-Baltzer GB, Gubareva LV, Nicholls JM, Pearce MB, Mishin VP, Belser JA, Chen LM, Chan RW, Chan MC, Hedlund M, et al. PLoS One. 2009 Nov 6; 4(11):e7788. Epub 2009 Nov 6.
Review Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Curr Opin Pulm Med. 2004
Review Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Brooks MJ, Sasadeusz JJ, Tannock GA. Curr Opin Pulm Med. 2004 May; 10(3):197-203.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.